Nice applauds mesothelioma drug U-turn

The National Institute for Health and Clinical Excellence has finally approved the use of Alimta, the chemotherapy treatment for mesothelioma, following a two-and-a-half-year appraisal process.


To continue reading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: